BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 9, 2019
View Archived Issues
Zoning affects tumor metabolism
Read More
RASER wire for cancer cells
Read More
Retinoic acid-induced protein 3, a marker of poor outcomes in esophageal cancer patients
Read More
NUP98 predicts poor outcomes in triple-negative breast cancer under anthracycline-based regimens
Read More
Scientists create model of congenital cytomegalovirus transmission after maternal reinfection
Read More
SEECASE trial finds efficacy of NOV-03 in treating dry eye disease
Read More
NEOLEV2 trial highlights the difficulty of treating neonatal seizures
Read More
First clinical data of an ARSB gene therapy for mucopolysaccharidosis type VI
Read More
Neuropore initiates phase I study of NPT-520-34
Read More
Phase I results presented for LY-3154207
Read More
Genetic knockout mice may be an improved model of neuropathic bladder
Read More
FDA allows IND application for phase I study of CB-03-10
Read More
Merck & Co. patents IDO1 inhibitors
Read More
Enrollment completed in second stage of phase II study of bemcentinib plus Keytruda in NSCLC
Read More
Unifying rare diseases may enable multiple treatments
Read More
Shionogi & Co. describes anti-influenza agents
Read More
ObsEva initiates phase III program for linzagolix in endometriosis-associated pain
Read More
IFM Tre discloses NLRP3 inflammasome inhibitors
Read More
First patient dosed in phase II trial of SRK-015 in type 2 and type 3 SMA
Read More
Phase II trial of 15-valent pneumococcal conjugate vaccine V-114 meets primary endpoint
Read More
Provention Bio reports phase Ib results for PRV-300 in ulcerative colitis
Read More
CJ HealthCare identifies JAK1 inhibitors
Read More
FDA clears IND for phase I/II trial of IDE-196 in tumors with GNAQ/11 mutations or PKC fusions
Read More
Texas State University discloses photoactivatable cancer prodrugs
Read More
Oyster Point studies long-term safety of OC-01 nasal spray in ONSET extension trial
Read More